Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Iovance Biotherapeutics Inc (IOVA) has issued an announcement.
General Merrill A. McPeak, a key figure on the Board of Directors for Iovance Biotherapeutics, Inc., has announced his upcoming retirement and will not seek re-election at the June 2024 annual stockholders’ meeting. His departure is amicable, with no conflicts cited regarding company operations or policies. In his place, the Board’s Nominating and Corporate Governance Committee has put forward Frederick G. Vogt, currently the Interim CEO and President of Iovance, as a nominee to fill the vacancy on the Board, effective from the date of the meeting.
For an in-depth examination of IOVA stock, go to TipRanks’ Stock Analysis page.